4//SEC Filing
Leonard John E. 4
Accession 0000891839-20-000213
CIK 0001205922other
Filed
Jul 26, 8:00 PM ET
Accepted
Jul 27, 4:16 PM ET
Size
11.4 KB
Accession
0000891839-20-000213
Insider Transaction Report
Form 4
VACCINEX, INC.VCNX
Leonard John E.
SVP, Development
Transactions
- Exercise/Conversion
Common Stock
2020-07-27$3.90/sh+1,000$3,900→ 1,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-07-27−1,000→ 3,000 totalExercise: $3.90Exp: 2029-03-14→ Common Stock (1,000 underlying)
Holdings
- 1,014(indirect: By LLC)
Common Stock
- 24,408
Stock Option (Right to Buy)
Exercise: $7.10Exp: 2025-12-22→ Common Stock (24,408 underlying) - 3,062
Stock Option (Right to Buy)
Exercise: $7.10Exp: 2025-12-23→ Common Stock (3,062 underlying) - 4,000
Stock Option (Right to Buy)
Exercise: $6.07Exp: 2030-02-24→ Common Stock (4,000 underlying)
Footnotes (3)
- [F1]Exercisable in full as of the date of this report.
- [F2]This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date.
- [F3]This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the February 25, 2020 grant date.
Documents
Issuer
VACCINEX, INC.
CIK 0001205922
Entity typeother
Related Parties
1- filerCIK 0001747997
Filing Metadata
- Form type
- 4
- Filed
- Jul 26, 8:00 PM ET
- Accepted
- Jul 27, 4:16 PM ET
- Size
- 11.4 KB